Literature DB >> 33552600

Sensitivity of Awaji Criteria and Revised El Escorial Criteria in the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) at First Visit in a Tunisian Cohort.

Bademain Jean Fabrice Ido1, Imen Kacem2, Mahamadi Ouedraogo1, Amina Nasri2, Saloua Mrabet2, Amina Gargouri2, Mouna Ben Djebara2, Bawindsongré Jean Kabore1, Riadh Gouider2.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal disease whose diagnosis and early management can improve survival. The most used diagnostic criteria are the revised El Escorial criteria (rEEC) and Awaji criteria (AC). The comparison of their sensitivities showed contradictory results. Our study aimed to compare the sensitivities of these two criteria in the diagnosis of definite ALS, at first visit, in a Tunisian hospital cohort.
MATERIALS AND METHODS: This was a retrospective study including 173 patients diagnosed with ALS at the Department of Neurology of the Razi Hospital between January 2003 and April 2018.After studying the clinical features of the disease in our study population,each patient was categorized according to the rEEC and AC based on data collected in his medical record during his first visit to our department. Then, we compared the sensitivities of these two criteria in the diagnosis of definite ALS.
RESULTS: Our Tunisian cohort was characterized by a slower disease progression. The sensitivity of the AC (69.4%) was significantly higher than that of the rEEC (40.5%) (p < 0.001). When the clinical signs evolved for less than 6 months, the sensitivities were 61% for AC and 12% for rEEC (p < 0.001). After 24 months of disease progression, the sensitivities were 78.2% for AC and 69.1% for rEEC (p = 0.063). It was impossible to categorize seventeen patients by the two criteria.
CONCLUSION: Our study demonstrated that patients in AC are more sensitive than rEEC in the early diagnosis of ALS in our Tunisian cohort. However, this superiority is gradually reduced during the evolution of the disease.
Copyright © 2021 Bademain Jean Fabrice Ido et al.

Entities:  

Year:  2021        PMID: 33552600      PMCID: PMC7847325          DOI: 10.1155/2021/8841281

Source DB:  PubMed          Journal:  Neurol Res Int        ISSN: 2090-1860


  32 in total

1.  Clinical features and associations of 560 cases of motor neuron disease.

Authors:  T M Li; E Alberman; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

Review 2.  Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review.

Authors:  João Costa; Michael Swash; Mamede de Carvalho
Journal:  Arch Neurol       Date:  2012-11

Review 3.  Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.

Authors:  Manoj Kumar Jaiswal
Journal:  Med Res Rev       Date:  2018-08-12       Impact factor: 12.944

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

5.  Improving survival in a large French ALS center cohort.

Authors:  Paul H Gordon; François Salachas; Gaelle Bruneteau; Pierre-François Pradat; Lucette Lacomblez; Jesus Gonzalez-Bermejo; Capucine Morelot-Panzini; Thomas Similowski; Alexis Elbaz; Vincent Meininger
Journal:  J Neurol       Date:  2012-01-19       Impact factor: 4.849

Review 6.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

Review 7.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

8.  Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study.

Authors:  Pierre Marie Preux; Benoit Marin; Jaime Luna; Mouhamadou Diagana; Leila Ait Aissa; Meriem Tazir; Lamia Ali Pacha; Imen Kacem; Riadh Gouider; Franclo Henning; Anna Basse; Ousmane Cisse; Agnon Ayélola Koffi Balogou; Damelan Kombate; Mendinatou Agbetou; Dismand Houinato; Athanase Millogo; Thierry Agba; Mouftao Belo; Marie Penoty; Marie Raymondeau-Moustafa; Bello Hamidou; Philippe Couratier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-09-21       Impact factor: 10.154

9.  Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.

Authors:  Susan T Paulukonis; Eric M Roberts; Jhaqueline P Valle; Natalie N Collins; Paul B English; Wendy E Kaye
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

10.  The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population.

Authors:  Da-Wei Li; Mingsheng Liu; Bo Cui; Jia Fang; Yu-Zhou Guan; Qingyun Ding; Xiaoguang Li; Liying Cui
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.